• phone 1-855-475-7782 | fax 1-855-475-7787

global pharmacy plus review
shop secure

Incruse Ellipta (Umeclidinium) 62.5mcg 30MDI - Brand Name

Product Details

Umeclidinium oral inhalation is used in adults to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, that includes chronic bronchitis and emphysema). Umeclidinium inhalation is in a class of medications called anticholinergics. It works by relaxing and opening air passages in the lungs, making it easier to breathe.

Each single inhalation provides a delivered dose (the dose leaving the mouthpiece of the inhaler) of 55 micrograms umeclidinium (equivalent to 65 micrograms of umeclidinium bromide). This corresponds to a pre-dispensed dose of 62.5 micrograms umeclidinium equivalent to 74.2 micrograms umeclidinium bromide.

Our European Brand Name product information:

Incruse Ellipta (Umeclidinium) 55mcg 30MDI

  • Quanity:1 Inhaler
  • Strength: 62.5mcg
Our Brand-Name Price:

Availability: In stock


There are no products matching the selection.

90.00 In stock